2nd Aug 2007 15:38
Oxford Biomedica PLC02 August 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): Oxford BioMedica PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: (Yes) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation (iii): Man Financial Limited 4. Full name of shareholder(s) (if different from 3.) (iv): 5. Date of the transaction (and date on which the threshold is crossed orreached if different) (v): 1 August 2007 6. Date on which issuer notified: 2 August 2007 7. Threshold(s) that is/are crossed or reached: 3% to 2% 8. Notified details: Below 3% A: Voting rights attached to shares Class/type of shares if possible using Situation previous to the Triggering transactionthe ISIN CODE (vi) Number of shares Number of voting Rights (viii) GB0006648157 21,070,855 21,070,855 Resulting situation after the triggering transaction (vii)Class/type of shares if Number of shares Number of voting rights (ix) % of voting rightspossible using the ISINCODE Direct Direct (x) Indirect (xi) Direct Indirect GB0006648157 Below 3% Below 3% Below 3% B: Financial Instruments Resulting situation after the triggering transaction (xii)Type of Expiration Date ( Exercise/Conversion Number of voting rights % of voting rightsfinancial xiii) Period/Date (xiv) that may be acquired ifinstrument the instrument is exercised/ converted. N/A N/A N/A N/A N/A Total (A+B) Number of voting rights % of voting rights 15,634,634 Below 3% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: None 14. Contact name: Andrew Wood 15. Contact telephone number: 01865 783000 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Oxford Biomedica